MediPharm Labs Corp.
MEDIF
$0.04
$0.00-1.65%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.56M | -2.72M | -269.70K | -1.23M | -2.03M |
| Total Depreciation and Amortization | 304.90K | 302.80K | 296.10K | 400.80K | 379.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.90K | 224.10K | 241.80K | -516.50K | 525.00K |
| Change in Net Operating Assets | 994.70K | 196.60K | -2.37M | 586.50K | 643.70K |
| Cash from Operations | -114.70K | -2.00M | -2.10M | -762.20K | -485.40K |
| Capital Expenditure | -11.60K | -30.40K | -29.30K | -31.40K | -24.20K |
| Sale of Property, Plant, and Equipment | 344.90K | 3.07M | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 333.30K | 3.04M | -29.30K | -31.40K | -24.20K |
| Total Debt Issued | 0.00 | 500.00K | -- | 0.00 | 50.00K |
| Total Debt Repaid | -120.00K | -84.00K | -265.00K | -337.00K | -2.29M |
| Issuance of Common Stock | -- | -- | -- | 14.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 47.00K | 31.00K | 56.00K | 79.00K | 20.00K |
| Cash from Financing | -53.00K | 323.10K | -145.60K | -174.30K | -1.63M |
| Foreign Exchange rate Adjustments | -4.40K | 27.50K | 11.10K | -33.60K | 13.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.20K | 1.39M | -2.26M | -1.00M | -2.13M |